Silver Bullet Therapeutics Announces FDA Approval of Pre-Market Study

Company Provides Update on Operations & EU Commercialization SAN JOSE, Calif., Jan. 15, 2025 /PRNewswire/ -- Silver Bullet Therapeutics, Inc., a privately-held medical device company, announced today that the Company now has approval to start a pre-market 510k study from the FDA. In...